{"id":21890,"date":"2023-09-08T14:45:00","date_gmt":"2023-09-08T14:45:00","guid":{"rendered":"https:\/\/www.prnasia.com\/story\/archive\/4204424_AE04424_0"},"modified":"2023-09-08T14:45:00","modified_gmt":"2023-09-08T14:45:00","slug":"sirtex-medical-announces-collaboration-agreement-with-magle-group-for-embocept-s-dsm-50-%ce%bcm","status":"publish","type":"post","link":"https:\/\/transmediavictoria.net.au\/?p=21890","title":{"rendered":"Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept\u00ae S DSM 50 \u03bcm"},"content":{"rendered":"<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2205547\/Sirtex_Medical_Logo.jpg?p=medium600\" border=\"0\" alt title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p class=\"prntac\"><i>Sirtex partners with Magle Group to advance the international treatment of liver and lung cancer<\/i><\/p>\n<p><span class=\"xn-location\">WOBURN, Mass.<\/span>, <span class=\"xn-chron\">Sept. 8, 2023<\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3963741-1&amp;h=131027584&amp;u=http%3A%2F%2Fwww.sirtex.com%2Fus%2F&amp;a=Sirtex+Medical+(%22Sirtex%22)\" target=\"_blank\" rel=\"nofollow noopener\">Sirtex Medical (&#8220;Sirtex&#8221;)<\/a>, a leading manufacturer of interventional treatment solutions, announced today the establishment of a collaboration and exclusive worldwide distribution agreement with Magle Group, a&nbsp;Sweden-based contract development and manufacturing organization as well as Degradable Starch Microspheres (DSM) sales and marketing company.<\/p>\n<p>Under the terms of the agreement, Sirtex will exclusively distribute Magle Group&#8217;s chemoembolization product, EmboCept<sup>\u00ae<\/sup> S DSM 50 \u03bcm, in the existing and new geographic areas to support expanded patient access to the product. Together, Sirtex and Magle also intend to establish a joint development plan to increase product range in the field of embolization by utilizing Magle Group&#8217;s DSM platform.<\/p>\n<p>Indicated for chemoembolization of liver and lung tumors, EmboCept<sup>\u00ae<\/sup> S DSM 50 \u03bcm is an adjuvant in the intra-arterial treatment of inoperable liver and lung tumors in combination with cytostatic agents. Due to its degradability, EmboCept<sup>\u00ae<\/sup> S can be applied for superselective treatments of single-liver segments and used for a selective targeting of one liver lobe to treat multifocal, diffuse tumors and non-visible micro tumors.<\/p>\n<p>&#8220;We are delighted to team up with Sirtex to unleash the full commercial potential of EmboCept<sup>\u00ae<\/sup>&nbsp;S, our proprietary product for chemoembolization of inoperable liver and lung tumours. Sirtex has a well-established sales force and is also well-equipped to support our continuous efforts to expand Magle Group&#8217;s DSM-based product range in the field of embolization,&#8221; says <span class=\"xn-person\">Justin Pierce<\/span>, CEO of Magle Group.&nbsp;<\/p>\n<p>According to the <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3963741-1&amp;h=2644831500&amp;u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC10121295%2F%23%3A%7E%3Atext%3DLiver%2520cancer%2520is%2520the%2520fourth%2Cand%2520other%2520primary%2520liver%2520malignancies.&amp;a=National+Institute+of+Health\" target=\"_blank\" rel=\"nofollow noopener\">National Institute of Health<\/a>, liver cancer is the fourth most common cause of death globally, accounting for over 800,000 deaths annually. As of 2020, the <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3963741-1&amp;h=149043182&amp;u=https%3A%2F%2Fwww.who.int%2Fnews-room%2Ffact-sheets%2Fdetail%2Flung-cancer&amp;a=World+Health+Organization\" target=\"_blank\" rel=\"nofollow noopener\">World Health Organization<\/a>&nbsp;found that 2.2 million people are diagnosed and 1.8 million people die from lung cancer yearly. This makes lung cancer responsible for the highest number of cancer-related deaths and the second most common cancer.<\/p>\n<p>&#8220;We are thrilled to expand our product portfolio to address unmet needs in liver and lung oncology,&#8221; said <span class=\"xn-person\">Kevin R. Smith<\/span>, Chief Executive Officer of Sirtex. &#8220;Our partnership with Magle will allow us to continue in our unrelenting pursuit to deliver quality treatments to improve patients&#8217; lives globally.&#8221;<\/p>\n<p>EmboCept<sup>\u00ae<\/sup> S DSM 50 \u00b5m is currently approved for sale in <span class=\"xn-location\">Europe<\/span>, <span class=\"xn-location\">Argentina<\/span>, <span class=\"xn-location\">Singapore<\/span>, and <span class=\"xn-location\">Malaysia<\/span>.<\/p>\n<p><b>About Sirtex<br \/><\/b>Sirtex is a global healthcare business with offices in the U.S., <span class=\"xn-location\">Australia<\/span>, <span class=\"xn-location\">Europe<\/span> and <span class=\"xn-location\">Asia<\/span>, working to improve outcomes in people with cancer. Sirtex&#8217;s current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres<sup>\u00ae<\/sup> <span class=\"xn-money\">Y-90<\/span> resin microspheres. For more information, visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3963741-1&amp;h=2165239692&amp;u=http%3A%2F%2Fwww.sirtex.com%2F&amp;a=www.sirtex.com\" target=\"_blank\" rel=\"nofollow noopener\">www.sirtex.com<\/a>.<\/p>\n<p>APM-GL-001-09-23<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sirtex partners with Magle Group to advance the international treatment of liver and lung cancer WOBURN, Mass., Sept. 8, 2023 \/PRNewswire\/ &#8212; Sirtex Medical (&#8220;Sirtex&#8221;), a leading manufacturer of interventional treatment solutions, announced today the establishment of a collaboration and exclusive worldwide distribution agreement with Magle Group, a&nbsp;Sweden-based contract development and manufacturing organization as well [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-21890","post","type-post","status-publish","format-standard","hentry","category-business-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept\u00ae S DSM 50 \u03bcm - My Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/transmediavictoria.net.au\/?p=21890\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept\u00ae S DSM 50 \u03bcm - My Blog\" \/>\n<meta property=\"og:description\" content=\"Sirtex partners with Magle Group to advance the international treatment of liver and lung cancer WOBURN, Mass., Sept. 8, 2023 \/PRNewswire\/ &#8212; Sirtex Medical (&#8220;Sirtex&#8221;), a leading manufacturer of interventional treatment solutions, announced today the establishment of a collaboration and exclusive worldwide distribution agreement with Magle Group, a&nbsp;Sweden-based contract development and manufacturing organization as well [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/transmediavictoria.net.au\/?p=21890\" \/>\n<meta property=\"og:site_name\" content=\"My Blog\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-08T14:45:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/2205547\/Sirtex_Medical_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin_tony\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin_tony\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21890#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21890\"},\"author\":{\"name\":\"admin_tony\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"headline\":\"Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept\u00ae S DSM 50 \u03bcm\",\"datePublished\":\"2023-09-08T14:45:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21890\"},\"wordCount\":443,\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21890#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2205547\\\/Sirtex_Medical_Logo.jpg?p=medium600\",\"articleSection\":[\"Business News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21890\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21890\",\"name\":\"Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept\u00ae S DSM 50 \u03bcm - My Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21890#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21890#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2205547\\\/Sirtex_Medical_Logo.jpg?p=medium600\",\"datePublished\":\"2023-09-08T14:45:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21890#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21890\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21890#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2205547\\\/Sirtex_Medical_Logo.jpg?p=medium600\",\"contentUrl\":\"https:\\\/\\\/mma.prnasia.com\\\/media2\\\/2205547\\\/Sirtex_Medical_Logo.jpg?p=medium600\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?p=21890#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept\u00ae S DSM 50 \u03bcm\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#website\",\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/\",\"name\":\"My Blog\",\"description\":\"My WordPress Blog\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/transmediavictoria.net.au\\\/#\\\/schema\\\/person\\\/5b51d407d652c0aa802bea269ea5d7e7\",\"name\":\"admin_tony\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g\",\"caption\":\"admin_tony\"},\"url\":\"https:\\\/\\\/transmediavictoria.net.au\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept\u00ae S DSM 50 \u03bcm - My Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/transmediavictoria.net.au\/?p=21890","og_locale":"en_US","og_type":"article","og_title":"Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept\u00ae S DSM 50 \u03bcm - My Blog","og_description":"Sirtex partners with Magle Group to advance the international treatment of liver and lung cancer WOBURN, Mass., Sept. 8, 2023 \/PRNewswire\/ &#8212; Sirtex Medical (&#8220;Sirtex&#8221;), a leading manufacturer of interventional treatment solutions, announced today the establishment of a collaboration and exclusive worldwide distribution agreement with Magle Group, a&nbsp;Sweden-based contract development and manufacturing organization as well [&hellip;]","og_url":"https:\/\/transmediavictoria.net.au\/?p=21890","og_site_name":"My Blog","article_published_time":"2023-09-08T14:45:00+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/2205547\/Sirtex_Medical_Logo.jpg?p=medium600","type":"","width":"","height":""}],"author":"admin_tony","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin_tony","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/transmediavictoria.net.au\/?p=21890#article","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/?p=21890"},"author":{"name":"admin_tony","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"headline":"Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept\u00ae S DSM 50 \u03bcm","datePublished":"2023-09-08T14:45:00+00:00","mainEntityOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=21890"},"wordCount":443,"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=21890#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/2205547\/Sirtex_Medical_Logo.jpg?p=medium600","articleSection":["Business News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/transmediavictoria.net.au\/?p=21890","url":"https:\/\/transmediavictoria.net.au\/?p=21890","name":"Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept\u00ae S DSM 50 \u03bcm - My Blog","isPartOf":{"@id":"https:\/\/transmediavictoria.net.au\/#website"},"primaryImageOfPage":{"@id":"https:\/\/transmediavictoria.net.au\/?p=21890#primaryimage"},"image":{"@id":"https:\/\/transmediavictoria.net.au\/?p=21890#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnasia.com\/media2\/2205547\/Sirtex_Medical_Logo.jpg?p=medium600","datePublished":"2023-09-08T14:45:00+00:00","author":{"@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7"},"breadcrumb":{"@id":"https:\/\/transmediavictoria.net.au\/?p=21890#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/transmediavictoria.net.au\/?p=21890"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/transmediavictoria.net.au\/?p=21890#primaryimage","url":"https:\/\/mma.prnasia.com\/media2\/2205547\/Sirtex_Medical_Logo.jpg?p=medium600","contentUrl":"https:\/\/mma.prnasia.com\/media2\/2205547\/Sirtex_Medical_Logo.jpg?p=medium600"},{"@type":"BreadcrumbList","@id":"https:\/\/transmediavictoria.net.au\/?p=21890#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/transmediavictoria.net.au\/"},{"@type":"ListItem","position":2,"name":"Sirtex Medical Announces Collaboration Agreement with Magle Group for EmboCept\u00ae S DSM 50 \u03bcm"}]},{"@type":"WebSite","@id":"https:\/\/transmediavictoria.net.au\/#website","url":"https:\/\/transmediavictoria.net.au\/","name":"My Blog","description":"My WordPress Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/transmediavictoria.net.au\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/transmediavictoria.net.au\/#\/schema\/person\/5b51d407d652c0aa802bea269ea5d7e7","name":"admin_tony","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/102836fe5f9cd6c64e96e90e7341dbc815b7d12726a85708326dc0db40afd906?s=96&d=mm&r=g","caption":"admin_tony"},"url":"https:\/\/transmediavictoria.net.au\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/21890","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=21890"}],"version-history":[{"count":0,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=\/wp\/v2\/posts\/21890\/revisions"}],"wp:attachment":[{"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=21890"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=21890"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/transmediavictoria.net.au\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=21890"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}